QT Imaging Reports Record 2025 Revenue, Exceeds Guidance, Projects $39M Revenue for 2026

summarizeSummary

QT Imaging Holdings announced record Q4 and full-year 2025 financial results, exceeding revenue guidance, and provided a strong 2026 revenue outlook of $39 million, signaling significant growth.

check_boxKey Events

• Record 2025 Financial Performance

  Reported record Q4 2025 revenue of $8.3 million, up 97% sequentially and 877% year-over-year. Full-year 2025 revenue reached $18.9 million, exceeding guidance of $18.0 million and representing 288% growth over 2024. Net loss improved by 60% in Q4 2025, and Adjusted EBITDA improved by 52% for the full year.

• Strong 2026 Revenue Outlook

  Projected 2026 revenue of approximately $39 million, including scanner shipments and initial revenue from its SaaS Cloud Platform, indicating a significant acceleration in growth.

• Strategic Partnerships and Distribution Expansion

  Entered collaborations with Intelerad Medical Systems and Olea Medical to enhance its QTI Cloud SaaS Platform. Secured an exclusive distribution agreement in the UAE with Al Naghi Medical Co., committing to minimum orders of 43 scanners for over $24 million in revenue from 2026-2028.

• Strengthened Financial Position and Market Presence

  Successfully completed a private placement raising $18.2 million in gross proceeds and uplisted to the Nasdaq Capital Market, enhancing financial stability and market visibility.

auto_awesomeAnalysis

QT Imaging Holdings delivered exceptionally strong financial results for 2025, surpassing its revenue guidance and demonstrating significant operational momentum. The company achieved record revenue in Q4 2025 and for the full year, driven by increased scanner shipments and strategic partnerships. The substantial 2026 revenue outlook of $39 million, more than double the 2025 figure, signals a robust growth trajectory and successful execution of its pivot towards a SaaS and biomarker-driven medical imaging platform. While the company reported a net loss, the improvement in Adjusted EBITDA and the focus on non-cash expenses indicate a healthier operational trend. The strategic collaborations and distribution agreements, particularly the multi-year UAE deal, underpin the ambitious future guidance and enhance the company's market reach and revenue visibility.